The 35 rating InvestorsObserver gives to Protalix Biotherapeutics Inc (PLX) stock puts it near the middle of the Biotechnology industry. In addition to scoring higher than 44 percent of stocks in the Biotechnology industry, PLX’s 35 overall rating means the stock scores better than 35 percent of all stocks.
What do These Ratings Mean?
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 35 means the stock is more attractive than 35 percent of stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Protalix Biotherapeutics Inc Stock Today?
Protalix Biotherapeutics Inc (PLX) stock is trading at $2.02 as of 10:44 AM on Monday, Jun 7, a drop of -$0.12, or -5.61% from the previous closing price of $2.14. The stock has traded between $2.02 and $2.07 so far today. Volume today is less active than usual. So far 771,602 shares have traded compared to average volume of 2,221,418 shares.
Click Here to get the full Stock Score Report on Protalix Biotherapeutics Inc (PLX) Stock.
